The same experiment, performed on serum derived from NMO patients, who both tested positive and negative for anti-AQP4 antibodies via the cell-killing assay, allowed for the selection of four peptoids NMOP2, NMOP5, NMOP6, and NMOP9 (Table 2). The gene discussed is AQP4; the disease is neuromyelitis optica.